IT8922312A0 - NEW METHOD OF TREATMENT OF VENTRICULAR ARRHYTHMIA - Google Patents

NEW METHOD OF TREATMENT OF VENTRICULAR ARRHYTHMIA

Info

Publication number
IT8922312A0
IT8922312A0 IT22312A IT2231289A IT8922312A0 IT 8922312 A0 IT8922312 A0 IT 8922312A0 IT 22312 A IT22312 A IT 22312A IT 2231289 A IT2231289 A IT 2231289A IT 8922312 A0 IT8922312 A0 IT 8922312A0
Authority
IT
Italy
Prior art keywords
treatment
new method
ventricular arrhythmia
arrhythmia
ventricular
Prior art date
Application number
IT22312A
Other languages
Italian (it)
Other versions
IT1239283B (en
IT8922312A1 (en
Inventor
Mauro Grossoni
Patrizia Salvati
Giorgio Ukmar
Lorenzo Vaga
Carlo Patrono
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Priority to IT22312A priority Critical patent/IT1239283B/en
Publication of IT8922312A0 publication Critical patent/IT8922312A0/en
Priority to JP2299683A priority patent/JPH03169826A/en
Priority to DE4035226A priority patent/DE4035226A1/en
Publication of IT8922312A1 publication Critical patent/IT8922312A1/en
Application granted granted Critical
Publication of IT1239283B publication Critical patent/IT1239283B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT22312A 1989-11-08 1989-11-08 USE OF A MUSCARINIC AGENT ALONE OR TOGETHER WITH A KNOWN ANTIARRHYTHMIC DRUG FOR THE PREVENTION AND / OR TREATMENT OF VENTRICULAR ARRHYTHMIA. IT1239283B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT22312A IT1239283B (en) 1989-11-08 1989-11-08 USE OF A MUSCARINIC AGENT ALONE OR TOGETHER WITH A KNOWN ANTIARRHYTHMIC DRUG FOR THE PREVENTION AND / OR TREATMENT OF VENTRICULAR ARRHYTHMIA.
JP2299683A JPH03169826A (en) 1989-11-08 1990-11-05 Use of drug having muscarinic action for preventing and treating ventricular arrhythmia
DE4035226A DE4035226A1 (en) 1989-11-08 1990-11-06 Use of medicament containing muscarine agonist - to prevent and treat ventricular arrhythmia, especially acute or malignant arrhythmia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22312A IT1239283B (en) 1989-11-08 1989-11-08 USE OF A MUSCARINIC AGENT ALONE OR TOGETHER WITH A KNOWN ANTIARRHYTHMIC DRUG FOR THE PREVENTION AND / OR TREATMENT OF VENTRICULAR ARRHYTHMIA.

Publications (3)

Publication Number Publication Date
IT8922312A0 true IT8922312A0 (en) 1989-11-08
IT8922312A1 IT8922312A1 (en) 1991-05-08
IT1239283B IT1239283B (en) 1993-10-19

Family

ID=11194522

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22312A IT1239283B (en) 1989-11-08 1989-11-08 USE OF A MUSCARINIC AGENT ALONE OR TOGETHER WITH A KNOWN ANTIARRHYTHMIC DRUG FOR THE PREVENTION AND / OR TREATMENT OF VENTRICULAR ARRHYTHMIA.

Country Status (3)

Country Link
JP (1) JPH03169826A (en)
DE (1) DE4035226A1 (en)
IT (1) IT1239283B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107949562B (en) * 2015-06-09 2021-07-23 拜耳制药股份公司 Positive allosteric modulators of muscarinic M2 receptors

Also Published As

Publication number Publication date
IT1239283B (en) 1993-10-19
IT8922312A1 (en) 1991-05-08
DE4035226A1 (en) 1991-05-16
JPH03169826A (en) 1991-07-23

Similar Documents

Publication Publication Date Title
GB8507985D0 (en) Treating disorders of cardiac rhythm
AP9000206A0 (en) Treatment of conditions & diseases
DE3587741T2 (en) Treatment of skin diseases.
GB8928934D0 (en) Treatment of birds
KR900700442A (en) New Arrhythmia Treatment I
IT8748403A0 (en) COMPOSITION OF SLOW-RELEASE FLUORIDE FOR THE TREATMENT AND PREVENTION OF BONE DISEASES
IT8922312A0 (en) NEW METHOD OF TREATMENT OF VENTRICULAR ARRHYTHMIA
EP0149519A3 (en) Method of treating heart disease
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
IT8520463A0 (en) TREATMENT OF OSTEOPOROSIS.
IT8520448A0 (en) TREATMENT OF OSTEOPOROSIS.
EP0436717A4 (en) Method of treatment with medical agents
IT1243088B (en) PLANT FOR THE PRODUCTION OF FOOTWEAR AND PROCEDURE FOR THE USE OF THIS PLANT
IT8421046A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ARRHYTHMIA AND RELATED ANTIARRHYTHMIC PROCESS.
GB2160099B (en) Treatment of athlete's foot
DE3668338D1 (en) CONTINUOUS TREATMENT OF TENSIVE TISSUE.
IT1191659B (en) WATER TREATMENT PROCEDURE
AU1162788A (en) Oxime-ethers of 2,6-dioxobicyclo-(3.3.0)octanones for treatment of heart and circulation diseases
EP0344820A3 (en) Means for the treatment of cardiac diseases
IT8847887A0 (en) INFERTILITY TREATMENT
JPS6490158A (en) 1,2-diamino compound, manufacture and medicine for treating cardiac disease and circulatory disease
IT1219592B (en) REACTIVATING LOTION FOR THE TREATMENT OF ALOPECIA
SE9003140D0 (en) METHOD AND COMPOSITION FOR TREATMENT OF HEART DISEASES
AU7491487A (en) Method of treating ischaemic vascular diseases using 4(benz-oxa/thia-diazole) -14-dihydropyridine der.
ZA85125B (en) Method of treating heart disease

Legal Events

Date Code Title Description
0001 Granted